GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amrutanjan Health Care Ltd (NSE:AMRUTANJAN) » Definitions » Capex-to-Operating-Income

Amrutanjan Health Care (NSE:AMRUTANJAN) Capex-to-Operating-Income : 0.00 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Amrutanjan Health Care Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Amrutanjan Health Care's Capital Expenditure for the three months ended in Mar. 2024 was ₹0.00 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₹147.03 Mil.

Hence, Amrutanjan Health Care's Capex-to-Operating-Income for the three months ended in Mar. 2024 was 0.00.


Amrutanjan Health Care Capex-to-Operating-Income Historical Data

The historical data trend for Amrutanjan Health Care's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amrutanjan Health Care Capex-to-Operating-Income Chart

Amrutanjan Health Care Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.10 0.03 0.31 0.23 0.15

Amrutanjan Health Care Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Amrutanjan Health Care's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Amrutanjan Health Care's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amrutanjan Health Care's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amrutanjan Health Care's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Amrutanjan Health Care's Capex-to-Operating-Income falls into.



Amrutanjan Health Care Capex-to-Operating-Income Calculation

Amrutanjan Health Care's Capex-to-Operating-Income for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-67.177) / 457.544
=0.15

Amrutanjan Health Care's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / 147.028
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amrutanjan Health Care  (NSE:AMRUTANJAN) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Amrutanjan Health Care Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Amrutanjan Health Care's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Amrutanjan Health Care (NSE:AMRUTANJAN) Business Description

Traded in Other Exchanges
Address
No. 103 (Old No. 42-45), Luz Church Road, Mylapore, Chennai, TN, IND, 600 004
Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkin, and inhaler. Geographically, it generates the majority of the revenue from India.

Amrutanjan Health Care (NSE:AMRUTANJAN) Headlines

No Headlines